Chickenpox is often thought of as a mild childhood illness, but it can cause serious complications, particularly in newborn babies, pregnant women, and people with weakened immune systems. Before the introduction of routine vaccination, chickenpox led to thousands of GP consultations, hospital admissions, and school absences in the UK each year.
Complications of chickenpox can include bacterial skin infections, pneumonia, and in rare cases, inflammation of the brain (encephalitis). The virus that causes chickenpox, varicella-zoster, also remains dormant in the body after infection and can reactivate later in life as shingles, a painful condition that affects around one in four people.
By vaccinating children against chickenpox as part of the routine NHS schedule, the aim is to significantly reduce the number of infections, complications, and hospitalisations. It also helps protect vulnerable individuals who cannot be vaccinated themselves through herd immunity. The chickenpox component of the MMRV vaccine is safe and highly effective, providing long-lasting protection against the disease.